Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry
JCO Clinical Cancer Informatics · 2024
DOI: 10.1200/cci.23.00251 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2024. Verfasst von Thales C Nepomuceno und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Hauptthemen laut MEDLINE: Breast Neoplasms, Germ-Line Mutation, BRCA1 Protein, BRCA2 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE The emergence of large real-world clinical databases and tools to mine electronic medical records has allowed for an unprecedented look at large data sets with clinical and epidemiologic correlates. In clinical cancer genetics, real-world databases allow for the investigation of prevalence and effectiveness of prevention strategies and targeted treatments and for the identification of barriers to better outcomes. However, real-world data sets have inherent biases and problems (eg, selection bias, incomplete data, measurement error) that may hamper adequate analysis and affect statistical power. METHODS Here, we leverage a real-world clinical data set from a large health network for patients with breast cancer tested for variants in BRCA1 and BRCA2 (N = 12,423). We conducted data cleaning and harmonization, cross-referenced with publicly available databases, performed variant reassessment and functional assays, and used functional data to inform a variant's clinical significance applying American College of Medical Geneticists and the Association of Molecular Pathology guidelines. RESULTS In the cohort, White and Black patients were over-represented, whereas non-White Hispanic and Asian patients were under-represented. Incorrect or missing variant designations were the most significant contributor to data loss. While manual curation corrected many incorrect designations, a sizable fraction of patient carriers remained with incorrect or missing variant designations. Despite the large number of patients with clinical significance not reported, original reported clinical significance assessments were accurate. Reassessment of variants in which clinical significance was not reported led to a marked improvement in data quality. CONCLUSION We identify the most common issues with BRCA1 and BRCA2 testing data entry and suggest approaches to minimize data loss and keep interpretation of clinical significance of variants up to date.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
- AdventHealth Research Institute, Orlando, FL.
- AdventHealth Cancer Institute, Orlando, FL.
- Syapse, San Francisco, CA.
- Department of Statistical Science, Duke University, Durham, NC.
- Mayo Clinic, Rochester, MN.
ORCID-Profile: Thales C Nepomuceno, Jianbin Zhu, Rachael H Martin, Daniel Lupu, Lauren C Peres, Anna Berry, Edwin S Iversen, Fergus J Couch, Qianxing Mo, Alvaro N Monteiro
Zitieren
APA
Nepomuceno, T. C., Lyra, P., Zhu, J., Yi, F., Martin, R. H., Lupu, D., Peterson, L., Peres, L. C., Berry, A., Iversen, E. S., Couch, F. J., Mo, Q., & Monteiro, A. N. (2024). Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.23.00251
Vancouver
Nepomuceno TC, Lyra P, Zhu J, Yi F, Martin RH, Lupu D, et al. Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO Clinical Cancer Informatics. 2024. doi:10.1200/cci.23.00251
BibTeX
@article{Nepomuceno2024,
author = {Nepomuceno, Thales C and Lyra, Paulo and Zhu, Jianbin and Yi, Fanchao and Martin, Rachael H and Lupu, Daniel and Peterson, Luke and Peres, Lauren C and Berry, Anna and Iversen, Edwin S and Couch, Fergus J and Mo, Qianxing and Monteiro, Alvaro N},
title = {Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry},
journal = {JCO Clinical Cancer Informatics},
year = {2024},
doi = {10.1200/cci.23.00251}
}
EUVIMED